Skip to content

Clinical trials

Observational Cardiomyopathy, Hypertrophic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Phase: Observational Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20131
20143
20201
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Unknown status4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Heidelberg University2
Bristol-Myers Squibb1
Deutsches Herzzentrum Muenchen1
German Heart Institute1
University Hospital Heidelberg1
University Hospital, Essen1
University of Virginia1
Universitätsklinikum Hamburg-Eppendorf1
Wuerzburg University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic10
Cardiomyopathy, Dilated5
Arrhythmogenic Right Ventricular Dysplasia3
Cardiomyopathies3
Heart Failure3
Amyloidosis2
Amyloid Neuropathies, Familial1
Brugada Syndrome1
Cardiomyopathy, Restrictive1
Fabry Disease1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.